https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Cancer Res. 2006 Nov;66(21):10247-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Cancer Res. 2006 Nov;66(21):10247-522006-11-01 00:00:002019-02-15 08:59:57Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Curr Opin Oncol 2006 Nov;18(6):631-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Curr Opin Oncol 2006 Nov;18(6):631-62006-11-01 00:00:002019-02-15 08:59:57Recent advances in immunotherapy for human glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):721-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):721-42006-11-01 00:00:002019-02-15 09:00:11A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / APMIS 2006 Oct;114(10):731-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / APMIS 2006 Oct;114(10):731-432006-10-01 00:00:002006-10-01 00:00:00Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-27 / J. Neurooncol. 2007 Jan;81(2):139-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-27 / J. Neurooncol. 2007 Jan;81(2):139-482006-09-27 00:00:002019-02-15 08:59:54Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-09-01 / Cancer Res. 2006 Sep;66(17):8887-96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-09-01 / Cancer Res. 2006 Sep;66(17):8887-962006-09-01 00:00:002019-02-15 08:59:58Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-502006-07-01 00:00:002019-02-15 09:00:00Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-312006-07-01 00:00:002019-02-15 09:00:01Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):233-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Expert Rev Vaccines 2006 Apr;5(2):233-472006-04-01 00:00:002019-02-15 09:00:02Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-02-04 / Cancer Immunol. Immunother. 2006 Nov;55(11):1309-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-02-04 / Cancer Immunol. Immunother. 2006 Nov;55(11):1309-192006-02-04 00:00:002019-02-15 08:59:59Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12
